These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12433532)

  • 21. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality control in the regulation of pharmaceuticals.
    Maynard A
    Pharmacoeconomics; 2005; 23(5):421-2. PubMed ID: 15896093
    [No Abstract]   [Full Text] [Related]  

  • 23. The challenges of globalization in pharmaceutical law--is an international drug approval system modeled after the European system worth considering?
    Purnhagen KP
    Food Drug Law J; 2008; 63(3):623-45. PubMed ID: 19031663
    [No Abstract]   [Full Text] [Related]  

  • 24. Vertical integration: the drug industry and prescription benefits managers.
    Gibaldi M
    Pharmacotherapy; 1995; 15(3):265-71. PubMed ID: 7667161
    [No Abstract]   [Full Text] [Related]  

  • 25. An Indian manufacturer's perspective for harmonization of guidelines for similar biotherapeutic products.
    Babu PV
    Biologicals; 2011 Sep; 39(5):300-3. PubMed ID: 21816621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New law introduces tougher rules on drug regulation in France.
    Benkimoun P
    BMJ; 2011 Dec; 343():d8309. PubMed ID: 22194407
    [No Abstract]   [Full Text] [Related]  

  • 27. Regulatory requirements with regard to the use of investigational new drugs.
    Hodges RM
    Antimicrob Agents Chemother (Bethesda); 1967; 7():16-8. PubMed ID: 5631922
    [No Abstract]   [Full Text] [Related]  

  • 28. Partial progress: governing the pharmaceutical industry and the NHS, 1948-2008.
    Abraham J
    J Health Polit Policy Law; 2009 Dec; 34(6):931-77. PubMed ID: 20018987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The pharmaceutical industry under discussion].
    Siemons GH
    Ned Tijdschr Geneeskd; 2005 Apr; 149(18):1007-9. PubMed ID: 15903044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulating pharmaceutical advertising: what will work?
    Shapiro MF
    CMAJ; 1997 Feb; 156(3):359-61. PubMed ID: 9033416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory guidelines for biosimilars in Malaysia.
    Abas A
    Biologicals; 2011 Sep; 39(5):339-42. PubMed ID: 21784655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Forcing pharmaceutical history into boxes.
    Carpenter D
    J Health Polit Policy Law; 2006 Oct; 31(5):1015-9. PubMed ID: 17193729
    [No Abstract]   [Full Text] [Related]  

  • 33. [European drug policy: welcomed modernization but shortage of political proposals concerning industry and research].
    Alván G
    Lakartidningen; 2003 Oct; 100(44):3541-2. PubMed ID: 14651017
    [No Abstract]   [Full Text] [Related]  

  • 34. [The drug industry and research: status in Germany].
    Geursen R
    Zentralbl Chir; 1996; 121(7):603-5. PubMed ID: 8967203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PBMs: ripe for regulation.
    Johnson RS
    Food Drug Law J; 2002; 57(2):323-69. PubMed ID: 12437004
    [No Abstract]   [Full Text] [Related]  

  • 36. US drug shortages are set to reach record high in 2011, report says.
    Tanne JH
    BMJ; 2011 Dec; 343():d8307. PubMed ID: 22194406
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmaceuticals, political money, and public policy: a theoretical and empirical agenda.
    Jorgensen PD
    J Law Med Ethics; 2013; 41(3):561-70. PubMed ID: 24088146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmaceutical companies and Italian Regional Governments: managing relationships in an increasing institutional complexity.
    Compagni A; Cavalli L; Jommi C
    Health Policy; 2008 Sep; 87(3):333-41. PubMed ID: 18384907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulating drug information in Europe: a pyrrhic victory for pharmaceutical industry critics?
    Mulinari S
    Sociol Health Illn; 2013 Jun; 35(5):761-77. PubMed ID: 23094890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescription drug pricing: do competitive forces operate in the pharmaceutical marketplace?
    Margolis RE
    Healthspan; 1994 Feb; 11(2):9-16. PubMed ID: 10132991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.